ArticleTheranostics2024
Abstract read
In one paragraph
Article in Theranostics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.
0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed.
- Assessment of liver fibrosis and tumor burden in hepatocellular carcinoma using [European journal of nuclear medicine and molecular imaging · 2026Trial
- Impact of spatial distribution of M2 macrophages on prognosis and neoadjuvant chemotherapy resistance in gastric cancer.Journal of gastrointestinal oncology · 2026Article
- Review
- Spatial ecotype in tumor immune exclusion: from spatial architecture to therapeutic strategies.Molecular cancer · 2026Review
- Unraveling the roles of fibroblast activation protein‑positive cancer‑associated fibroblasts in cancer: From mechanisms to therapy (Review).International journal of oncology · 2026Review
- Advances in the Molecular Mechanisms of Cholangiocarcinoma: A Comprehensive Review of Biomarkers, Regulatory Pathways and Tumor Microenvironment Reprogramming.International journal of molecular sciences · 2026Review
- Review
- Single-Cell RNA-Seq Combined With Bulk RNA-Seq Revealed the Involvement of Pancreatic Cancer Tissue-Resident Macrophages in Tumour Progression and the Immunotherapy Response.Journal of cellular and molecular medicine · 2026Article
- Bidirectional crosstalk between cancer-associated fibroblasts and tumor immunity: shaping the microenvironment and response to immune checkpoint therapy.Experimental hematology & oncology · 2026Review
- Abnormal adnexal uptake inJournal of ovarian research · 2026Article
- Analysis of the effect of platelet-derived growth factor combined with T cells in the diagnosis of hepatocellular carcinoma and prognostic assessment: A prospective cohort study.Journal of medical biochemistry · 2026Article
- Targeting Tumor-Associated Macrophages and Cancer-Associated Fibroblasts to Overcome Therapeutic Resistance in Hepatocellular Carcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026Review
- Deciphering lung adenocarcinoma heterogeneity: a multi-omics approach reveals nuclear division fibroblasts as prognosticators and therapeutic targets.Journal of translational medicine · 2026Article
- Sphingolipids in human disease: organ-specific pathologies, chain-length-dependent effects, and translational implications.Journal of translational medicine · 2026Review
- Obesity and Cancer: From Systemic Metabolic Reprogramming to Immunotherapy Paradox.Metabolites · 2026Review
- Exploring single-cell and multi-omics technologies and their role in unraveling tumor heterogeneity of hepatocellular carcinoma.Journal of liver cancer · 2026Review
- [Heterogeneity of tumor-associated macrophages and precision targeting strategies in hepatocellular carcinoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026Review
- Spatial Location of SPP1Cancer science · 2026Article
- An Immune-privileged niche mediates immunotherapy resistance in esophageal carcinoma.Journal for immunotherapy of cancer · 2026Article
- Formation and remodeling of immunological niches in solid tumors: organ-specific architectures, inflammatory parallels, and therapeutic reprogramming.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Fei LongDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Wei ZhongDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Faming ZhaoCenter for Single-Cell Omics and Tumor Liquid Biopsy, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yaqi XuDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xin HuDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Gaihua JiaDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Lanxiang HuangDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Kezhen YiDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Na WangDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Huaqi SiDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jun WangDepartment of Laboratory Medicine, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Bicheng WangDepartment of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yuan RongCenter for Single-Cell Omics and Tumor Liquid Biopsy, Zhongnan Hospital of Wuhan University, Wuhan, China.
Yufeng YuanDepartment of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
Chunhui YuanDepartment of Laboratory Medicine, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Fubing WangDepartment of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Cancer-Associated FibroblastsCarcinoma, HepatocellularLiver NeoplasmsTumor MicroenvironmentAdaptor Proteins, Signal TransducingCholangiocarcinomaEndopeptidasesFemaleFibroblast Activation Protein AlphaHumansImmunotherapyMacrophagesMaleMembrane ProteinsTumor-Associated MacrophagesAdaptor Proteins, Signal TransducingEndopeptidasesFibroblast Activation Protein AlphaMembrane ProteinsDAB2+ macrophageFAP+ fibroblastimmune exclusionprognosissingle-cell RNA sequencing
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.